Popular Articles
Stretch Mark Cream

AXURA(R)/AKATINOL(R) Enhances Communication Abilities In Patients With Alzheimer÷´s Disease - for A Longer Integration In Social And Family Life
Memantine improves functional communication skills in patients with moderate to severe Alzheimer"s disease (AD), noticeable by caregivers. These are the study results discussed at the International Conference on Alzheimer"s Disease (ICAD). The data of two recent clinical trials support that AXURA®/AKATINOL® - an uncompetitive NMDA receptor antagonist - effects language skills in AD patients and improves cognitive abilities and functional communication. Leading neurologists emphasize that improvement of communication skills is a meaningful treatment target. Communication breakdown can trigger feelings of frustration in Alzheimer"s patients and these feelings may manifest as behavioral instability. This in turn is known to be a major of caregiver"s burden and distress.
generic viagra online
What Is Hypertension? What Causes Hypertension?
Hypertension or high blood pressure is a condition in which the blood pressure in the arteries is chronically elevated. With every heart beat, the heart pumps blood through the arteries to the rest of the body. Blood pressure is the force of blood that is pushing up against the walls of the blood vessels. If the pressure is too high, the heart has to work harder to pump, and this could lead to organ damage and several illnesses such as heart attack, stroke, heart failure, aneurysm, or renal failure. Drugshop to buy zoloft online and other pills.
News of the day
America's Health Insurance Plans Statement On Health Care Reform Rhetoric
America"s Health Insurance Plans (AHIP) released the following statement from spokesman Robert Zirkelbach.
Mental Health

Bone Cancer Research Trust Calls For New Treatments For Bone Cancer

The Bone Cancer Research Trust is calling for new treatments for bone cancers affecting children and young people. This includes osteosarcoma and Ewing"s sarcoma, the two most common forms of primary bone cancer. A study funded by the Bone Cancer Research Trust published in 2009 shows that the survival of children and young adults with bone cancer in the UK has not improved for 20 years.(1) More research is urgently needed to find new treatments. When new treatments are developed, they must be introduced without delay to avoid any more young people dying of this disease. On average a young person cured of this disease would have another 60 years of life. One new treatment for osteosarcoma that improves survival is currently being considered for funding by NICE. BCRT is asking that this drug be made available as quickly as possible. Michael Francis, chairman of the BCRT said "Too many of the children and young people with bone cancer still die from their disease. We need to make bone cancer a priority and we urgently need more research to identify effective new treatments. The Government needs to play its part and streamline the process for introducing new treatments into the UK." To support people affected by bone cancer, the Bone Cancer Research Trust is holding an Awareness Week during 20 - 27 June 2009. The theme for the week is the need to improve survival for these young people: this means greater priority, more research and new treatments. The week will finish with the 3rd Conference for bone cancer patients and their supporters, to be held in St Albans on Saturday 27 June. The conference will cover recent research and will give patients and their families the opportunity to question experts in bone cancer. Twenty eight year old Hannah Millington, from Bromsgrove, who has been treated for osteosarcoma says, ""Awareness Week and the Patients" and Supporters" Conference are key events for patients. They are an opportunity to raise awareness about this awful disease and to meet other people who are affected. Bone cancer is quite rare and it is easy for young people with the illness to feel extremely isolated." The Awareness Week is supported by, the Teenage Cancer Trust, Sarcoma UK, Cancer 52 and the Rarer Cancers Forum. Reference (1): Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981-2002. Eyre et al. British Journal of Cancer. Volume 100, Issue 1. January, 2009 About bone cancer The two commonest forms of bone cancer are osteosarcoma and Ewing"s sarcoma. Both of these cancers most commonly occur between the ages of 10 and 25. Because these cancers can spread to other parts of the body, even when the tumour is detected at a very small size, treatment includes chemotherapy. Chemotherapy is intended to destroy the tumour cells which have spread to the rest of the body and to shrink the main mass of tumour cells. Successful treatment also requires another form of treatment to the main mass of tumour. For osteosarcoma this is usually surgery to remove the main tumour and may involve replacing the affected bone with a metal alternative or amputation. Ewing"s sarcoma is similarly often treated with surgery, but treatment also includes radiotherapy which is intended to kill any residual cells. Around 400 patients are diagnosed each year in the UK with primary bone cancers. Bone Cancer Research Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):